Researchers from Ludwig Maximilian University have developed a simple walking test to diagnose idiopathic normal pressure hydrocephalus, a cause of dementia.
In this review article from Neurodegenerative Disease Management, discover how Parkinson’s disease psychosis may be optimally diagnosed and managed to improve quality of life.
Detecting caffeine levels in the blood may help to diagnose Parkinson’s disease, especially in its early stages.
This review from Biomarkers in Medicine explores the potential use of blood cell biomarkers in diagnosing Alzheimer’s disease as an alternative to traditional methods.
A recent study has suggested that physicians could determine whether a patient has major depression or bipolar disorder with a simple short electrocardiogram.
Salivary biomarkers have proven more accurate for identifying prolonged concussion than current methods.
Using FTIR spectroscopy and chemometirc techniques, researchers were able to successfully diagnose and differentiate between various neurodegenerative diseases including Alzheimer’s disease.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
A biomarker to aid in the diagnosis of ischemic stroke and its causes would be of value in acute clinical practice. It could have applications to aid in acute stroke treatment decisions for tissue plasminogen activator and/or the triage to endovascular therapy. This review provides an overview of RNA as a novel biomarker for the diagnosis and assessment of ischemic stroke.
CST5, AXIN1 and TRAIL identified patients with brain injury within an hour of the incident occurring.